血漿療法市場:各類型，各用途，各終端用戶，各地區-規模，佔有率，展望，機會分析，2023年～2030年

全球血漿治療市場預計在預測期內（2023-2030 年）複合年增長率為 14.2%。

血漿療法是治療冠狀病毒和許多其他罕見和嚴重疾病的一種有前途的治療方法。捐贈者提供的血液在處理設施中進行處理以獲得血漿。同樣，血漿從捐贈者中分離出來用於治療冠狀病毒感染的患者。捐贈者也可以是從感染中康復的患者。捐贈者的血漿由抗原或對抗冠狀病毒的抗體組成。捐贈者的血液在處理中心進行處理並注入患者的血液中。

市場動態

監管機構有興趣進行臨床試驗，為感染冠狀病毒的患者開發新的治療方法。例如，2020 年 4 月 18 日，印度藥品監管總局 (DCGI) 宣布，印度醫學研究委員會 (ICMR) 作為印度製定、協調和促進生物醫學研究的最高機構，將接受一項提案，開展恢復期血漿的臨床試驗。ICMR已提交了對此臨床試驗感興趣的研究機構名單。恢復期血漿療法包括從 COVID-19 康復患者的血液中採集抗體，並將其注射到已注射患者的血液中。此臨床試驗旨在評估恢復期血漿在減少 COVID-19 患者併發症方面的有效性，並評估抗 SARS-CoV-2 血漿治療冠狀病毒感染患者的安全性。臨床試驗的增加預計將增加冠狀病毒感染患者的治療選擇，並推動預測期內全球血漿治療市場的成長。

該公司已獲得監管部門批准建立新的製造工廠。例如，武田製藥於 2021 年獲得美國食品藥物管理局 (FDA) 的批准，在喬治亞州卡溫頓附近設立新的藥品生產設施。該廠將生產 Flexbumin 25% [白蛋白（人），USP，25% 溶液]。此藥適用於低滲透壓血症、低蛋白血症、燒傷、成人呼吸窘迫症候群、腎臟病、體外循環手術和新生兒溶血病。新工廠預計將擴大公司的產品組合，並有利於預測期內全球血漿治療市場的成長。

本調查的主要特徵

• 本報告提供以2022年為基準年的預測期間（2023-2030 年）之全球血漿療法市場的市場規模和復合年增長率（CAGR %）相關的詳區隔析。
• 並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
• 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
• 並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球血漿療法市場的主要參與者之企業簡介。
• 藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 全球血漿療法市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以透過全球血漿療法市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

• 調查目的
• 前提條件
• 簡稱

第2章 市場概況

• 報告概要
  • 市場定義和範圍
• 摘要整理
• Coherent Opportunity Map(COM)

第3章 市場動態，法規，趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機會
• 影響分析
• 最近的產品銷售
• 流行病學
• 合併和收購
• 產品核可
• 夥伴關係和合作
• 研究開發活動
• 法規情勢
• 主要的發展
• PEST分析

第4章 由於血漿療法的全球市場:COVID-19的影響分析

• 經濟影響
• COVID-19流行病學
• 供需的影響

第5章 血漿療法的全球市場:各類型，2018-2030年

• 純PRP
• 富含白血球的PRP
• 純富血小板纖維蛋白(PRF)
• 富含白血球纖維蛋白(L-PRF)

第6章 血漿療法的全球市場:各用途，2018-2030年

• 感染疾病
• 牙科
• 神經損傷
• 心肌損傷
• 其他的應用

第7章 血漿療法的全球市場:各終端用戶，2018年～2030年

• 醫院及診所
• 研究機關
• 其他

第8章 血漿療法的全球市場:各地區，2018-2030年

• 北美
• 美國
• 加拿大
• 南美
• 巴西
• 墨西哥
• 阿根廷
• 其他南美國家
• 歐洲
• 英國
• 德國
• 義大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• ASEAN
• 澳洲
• 韓國
• 其他亞太地區
• 中東
• GCC
• 以色列
• 其他中東
• 非洲
• 北非
• 中非
• 南非

第9章 競爭情形

• Octapharma AG
• Top Bio Group Co., Ltd
• Bio Products Laboratory Ltd
• Kedrion S.p.A
• Grifols, S.A
• CSL
• Biotest AG
• Takeda Pharmaceutical Company Limited
• DePuy Synthes(A subsidiary of Johnson & Johnson Services, Inc.)
• Regen Lab SA
• LFB S.A
• ImmunoTek Plasma

第10章 章節

• 調查手法
• 關於出版社

The global plasma therapy market is estimated to be valued at US$ 334.5 Mn in 2023 and is expected to exhibit a CAGR of 14.2% during the forecast period (2023-2030).

Plasma therapy is a promising treatment against coronaviruses, and many rare other and serious disorders. The blood that is donated by the donor is processed in a processing facility to obtain plasma. Similarly, for the treatment of coronavirus-infected patients, the plasma is isolated from the donor. The donor is also the patient who has recovered from the infection. The donor plasma consists of antibodies that were generated in order to fight the antigens, i.e., the coronavirus. The blood from the donor is processed in processing centers and then injected into the blood of the patients.

Market Dynamics

Regulatory authorities are interested in conducting clinical trials for the development of new treatment options for coronavirus infected patients. For instance, on April 18, 2020, The Drug Controller General of India (DCGI) accepted the proposal of the Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination, and promotion of biomedical research, for conducting clinical trials of convalescent plasma in COVID-19 patients. The ICMR has submitted a list of institutes that are interested in the trial. In convalescent plasma therapy, the antibodies are recovered from the blood of patients who have recovered from COVID-19 and injected into the blood of injected patients. The clinical trial aims to assess the efficacy of convalescent plasma to limit complications in COVID-19 patients and to evaluate the safety of treatment with anti SARS-CoV-2 plasma in coronavirus-infected patients. The rising number of clinical trials is expected to increase treatment options for coronavirus infected patients and spur global plasma therapy market growth during the forecast period.

Companies are receiving approvals from regulatory authorities for the setup of a new manufacturing facility. For instance, in 2021, Takeda Pharmaceutical Company Limited received approval from the U.S Food and Drug Administration (U.S FDA) for its new pharmaceutical manufacturing facility near Covington, Georgia. The facility will produce FLEXBUMIN 25% [Albumin (Human), USP, 25% Solution]. The medicine is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome, and nephrosis, cardiopulmonary bypass surgery, and hemolytic disease of newborns. The new facility will expand the product portfolio of the company which is expected to favor the global plasma therapy market growth during the forecast period.international distributors.

Key features of the study:

• This report provides an in-depth analysis of the global plasma therapy market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global plasma therapy market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Octapharma AG, Top Bio Group Co., Ltd, Bio Products Laboratory Ltd, Kedrion S.p.A, Grifols, S.A, CSL, Biotest AG, Takeda Pharmaceutical Company Limited, DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.), Regen Lab SA, LFB S.A, ImmunoTek Plasma.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global plasma therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plasma therapy market.

Detailed Segmentation:

• Global Plasma Therapy Market, By Type:
  • Pure PRP
  • Leucocyte-rich PRP
  • Pure Platelet-rich Fibrin (PRF)
  • Leukocyte-rich Fibrin (L-PRF)
• Global Plasma Therapy Market, By Appication:
  • Infectious Diseases
  • Dental
  • Nerve Injury
  • Cardiac Muscle Injury
  • Other Applications
• Global Plasma Therapy Market, By End user:
  • Hospitals and Clinics
  • Research Institutes
  • Others
• Global Plasma Therapy Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Octapharma AG
  • Top Bio Group Co., Ltd
  • Bio Products Laboratory Ltd
  • Kedrion S.p.A
  • Grifols, S.A
  • Cochin Shipyard Limited
  • Biotest AG
  • Takeda Pharmaceutical Company Limited
  • DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
  • Regen Lab SA
  • LFB S.A
  • ImmunoTek Plasma

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End user
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Mergers and Acquisition
• Product Approvals
• Partnerships and Collaborations
• Research and Development Activities
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Plasma Therapy Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Plasma Therapy Market, By Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Pure PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leucocyte-rich PRP
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Pure Platelet-rich Fibrin (PRF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leukocyte-rich Fibrin (L-PRF)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Plasma Therapy Market, By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Infectious Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Dental
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Nerve Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Cardiac Muscle Injury
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Plasma Therapy Market, By End user, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Plasma Therapy Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018- 2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Octapharma AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Top Bio Group Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bio Products Laboratory Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Kedrion S.p.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Grifols, S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CSL
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biotest AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Takeda Pharmaceutical Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• DePuy Synthes (A subsidiary of Johnson & Johnson Services, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Regen Lab SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LFB S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ImmunoTek Plasma
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us